Orthofix has appointed Patrick Fisher as president of its global orthopedics business. He will serve on the company’s executive leadership team, reporting to president and CEO Massimo Calafiore.
 
Fisher joins Orthofix from Stryker, where he served as the VP and GM of the Foot and Ankle business. Before Stryker, he was president of Lower Extremity and Biologics for Wright Medical, which Stryker acquired in 2020.
 
He also a board member of the Greater Memphis Medical Device Council, the Memphis Chairman’s Circle and the University of Tennessee Research Advisory Board.
 
“Patrick has led global teams in the successful development and execution of innovative strategies focused on driving commercial optimization across sales, marketing, R&D, clinical research and medical education,” said Calafiore. “We are excited to welcome him to our team, and I am confident his leadership, experience and broad familiarity with the Orthopedics market will help us further grow this franchise and expand our market presence.”
 
“Orthofix has a uniquely differentiated orthopedics portfolio with a history of clinical innovation that goes back to its early beginnings in 1980,” said Fisher. “I have long been aware of the great products and work done by the Orthofix orthopedics team, and I am honored to have the opportunity to lead this area of the organization. I look forward to working with the team to help drive growth and accelerate this important area of the business.”